Cargando…
Design and Optimization of Pioglitazone Hydrochloride Self-Nanoemulsifying Drug Delivery System (SNEDDS) Incorporated into an Orally Disintegrating Tablet
Pioglitazone Hydrochloride (PGZ) suffers from poor aqueous solubility. The aim of this research was to design orally disintegrating tablets with self-nanoemulsifying properties (T-SNEDDS) to improve the Pioglitazone solubility and dissolution rate. Three liquid self-nanoemulsifying systems (L-SNEDDS...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880587/ https://www.ncbi.nlm.nih.gov/pubmed/35214157 http://dx.doi.org/10.3390/pharmaceutics14020425 |
_version_ | 1784659250465734656 |
---|---|
author | Teaima, Mahmoud Hababeh, Sandra Khanfar, Mai Alanazi, Fares Alshora, Doaa El-Nabrawi, Mohammed |
author_facet | Teaima, Mahmoud Hababeh, Sandra Khanfar, Mai Alanazi, Fares Alshora, Doaa El-Nabrawi, Mohammed |
author_sort | Teaima, Mahmoud |
collection | PubMed |
description | Pioglitazone Hydrochloride (PGZ) suffers from poor aqueous solubility. The aim of this research was to design orally disintegrating tablets with self-nanoemulsifying properties (T-SNEDDS) to improve the Pioglitazone solubility and dissolution rate. Three liquid self-nanoemulsifying systems (L-SNEDDS) were formulated and evaluated for transmittance percentage, emulsification time, particle size, Poly dispersity index (PDI), percentage of content, solubility and stability. The optimum L-SNEDDS formula was converted to a solidified self-nanoemulsifying drug delivery system (S-SNEDDS) by adsorption on Syloid (SYL). Powder characterization tests, such as flowability tests, differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD) and scanning electron microscopy (SEM), were performed for the selected S-SNEDDS formulation. Orally disintegrating tablets (ODT) were formulated by blending S-SNEDDS with tableting excipients. The ODT tablet batch composed of Prosolv was selected for tablet quality control tests, such as hardness, friability, disintegration time, content uniformity, weight variation, in vitro release, in vivo studies and accelerated stability studies. ODT tablets showed accepted mechanical properties and rapid disintegration time (<30 s). No drug degradation was observed at 3 months into the accelerated stability study. The optimized L-SNEDDS, S-SNEDDS and ODT (T-SNEDDS), showed significant enhancement of PGZ in vitro dissolution profiles compared to the pure drug (p > 0.05). In vivo pharmacokinetic and pharmacodynamic evaluation of ODTs showed better behavior compared to the raw drug suspension and the commercial tablet (p > 0.05). Orally disintegrating tablets revealed a promising potential to improve Pioglitazone poor aqueous solubility, dissolution profile and bioavailability. |
format | Online Article Text |
id | pubmed-8880587 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88805872022-02-26 Design and Optimization of Pioglitazone Hydrochloride Self-Nanoemulsifying Drug Delivery System (SNEDDS) Incorporated into an Orally Disintegrating Tablet Teaima, Mahmoud Hababeh, Sandra Khanfar, Mai Alanazi, Fares Alshora, Doaa El-Nabrawi, Mohammed Pharmaceutics Article Pioglitazone Hydrochloride (PGZ) suffers from poor aqueous solubility. The aim of this research was to design orally disintegrating tablets with self-nanoemulsifying properties (T-SNEDDS) to improve the Pioglitazone solubility and dissolution rate. Three liquid self-nanoemulsifying systems (L-SNEDDS) were formulated and evaluated for transmittance percentage, emulsification time, particle size, Poly dispersity index (PDI), percentage of content, solubility and stability. The optimum L-SNEDDS formula was converted to a solidified self-nanoemulsifying drug delivery system (S-SNEDDS) by adsorption on Syloid (SYL). Powder characterization tests, such as flowability tests, differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD) and scanning electron microscopy (SEM), were performed for the selected S-SNEDDS formulation. Orally disintegrating tablets (ODT) were formulated by blending S-SNEDDS with tableting excipients. The ODT tablet batch composed of Prosolv was selected for tablet quality control tests, such as hardness, friability, disintegration time, content uniformity, weight variation, in vitro release, in vivo studies and accelerated stability studies. ODT tablets showed accepted mechanical properties and rapid disintegration time (<30 s). No drug degradation was observed at 3 months into the accelerated stability study. The optimized L-SNEDDS, S-SNEDDS and ODT (T-SNEDDS), showed significant enhancement of PGZ in vitro dissolution profiles compared to the pure drug (p > 0.05). In vivo pharmacokinetic and pharmacodynamic evaluation of ODTs showed better behavior compared to the raw drug suspension and the commercial tablet (p > 0.05). Orally disintegrating tablets revealed a promising potential to improve Pioglitazone poor aqueous solubility, dissolution profile and bioavailability. MDPI 2022-02-16 /pmc/articles/PMC8880587/ /pubmed/35214157 http://dx.doi.org/10.3390/pharmaceutics14020425 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Teaima, Mahmoud Hababeh, Sandra Khanfar, Mai Alanazi, Fares Alshora, Doaa El-Nabrawi, Mohammed Design and Optimization of Pioglitazone Hydrochloride Self-Nanoemulsifying Drug Delivery System (SNEDDS) Incorporated into an Orally Disintegrating Tablet |
title | Design and Optimization of Pioglitazone Hydrochloride Self-Nanoemulsifying Drug Delivery System (SNEDDS) Incorporated into an Orally Disintegrating Tablet |
title_full | Design and Optimization of Pioglitazone Hydrochloride Self-Nanoemulsifying Drug Delivery System (SNEDDS) Incorporated into an Orally Disintegrating Tablet |
title_fullStr | Design and Optimization of Pioglitazone Hydrochloride Self-Nanoemulsifying Drug Delivery System (SNEDDS) Incorporated into an Orally Disintegrating Tablet |
title_full_unstemmed | Design and Optimization of Pioglitazone Hydrochloride Self-Nanoemulsifying Drug Delivery System (SNEDDS) Incorporated into an Orally Disintegrating Tablet |
title_short | Design and Optimization of Pioglitazone Hydrochloride Self-Nanoemulsifying Drug Delivery System (SNEDDS) Incorporated into an Orally Disintegrating Tablet |
title_sort | design and optimization of pioglitazone hydrochloride self-nanoemulsifying drug delivery system (snedds) incorporated into an orally disintegrating tablet |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880587/ https://www.ncbi.nlm.nih.gov/pubmed/35214157 http://dx.doi.org/10.3390/pharmaceutics14020425 |
work_keys_str_mv | AT teaimamahmoud designandoptimizationofpioglitazonehydrochlorideselfnanoemulsifyingdrugdeliverysystemsneddsincorporatedintoanorallydisintegratingtablet AT hababehsandra designandoptimizationofpioglitazonehydrochlorideselfnanoemulsifyingdrugdeliverysystemsneddsincorporatedintoanorallydisintegratingtablet AT khanfarmai designandoptimizationofpioglitazonehydrochlorideselfnanoemulsifyingdrugdeliverysystemsneddsincorporatedintoanorallydisintegratingtablet AT alanazifares designandoptimizationofpioglitazonehydrochlorideselfnanoemulsifyingdrugdeliverysystemsneddsincorporatedintoanorallydisintegratingtablet AT alshoradoaa designandoptimizationofpioglitazonehydrochlorideselfnanoemulsifyingdrugdeliverysystemsneddsincorporatedintoanorallydisintegratingtablet AT elnabrawimohammed designandoptimizationofpioglitazonehydrochlorideselfnanoemulsifyingdrugdeliverysystemsneddsincorporatedintoanorallydisintegratingtablet |